| Objective To investigate the clinical effect of azithromycin sequential therapy, terbutaline nebulized inhalation combined with vitamin D in the treatment of pneumonia in children. Methods From August 2019 to June 2020, 120 pediatric pneumonia patients from Lixin County People’s Hospital in Anhui Province were divided into observation group and control group with 60 patients in each group. The control group was given azithromycin sequential therapy, and the observation group received terbutaline nebulized inhalation combined with vitamin D on the basis of the control group. After two weeks, the main clinical symptoms of the two groups of children were compared with the improvement time (fever disappearance time, cough disappearance time, breathing normal time, normal time of CRP, disappearance time of chest X-ray, hospitalization time), the treatment effect rates and adverse reactions of the two groups of children, and the recurrence rate (nausea and vomiting, shiver, diarrhea, erythry) of pneumonia after six months of follow-up were compared. Results The disappearance time of fever, cough disappearance, normal breathing time, normal CRP time, chest X-ray shadow disappearance time and hospital stay time of children in the observation group were significantly better than those of the control group, and the difference was statistically significant (P<0.05); the effective rate of treatment in the observation group was 96.7%, which was higher than that of the control group (83.4%), and the incidence of adverse reactions of children in the observation group was 21.7%, which was higher than that of the control group (13.3%), and the recurrence rate after six months was 8.3%, which was lower than that of the control group (15.0%), and the differences were statistically different (P<0.05). Conclusions The azithromycin sequential therapy, terbutaline nebulized inhalation combined with vitamin D in the treatment of pneumonia in children can significantly shorten the course of the disease, improve the curative effect and reduce recurrence. Thus, it is worth clinical application. |
